e18034Background: A phase 3 trial (NCT01542931) demonstrated failure to improve survival when docetaxel, cisplatin, and 5-fluorouracil (TPF) based induction chemotherapy was added to standard thera... Click to show full abstract
e18034Background: A phase 3 trial (NCT01542931) demonstrated failure to improve survival when docetaxel, cisplatin, and 5-fluorouracil (TPF) based induction chemotherapy was added to standard thera...
               
Click one of the above tabs to view related content.